1 | episodes | 8,863 |
2 | outbreaks | 498 |
3 | incidents | 458 |
4 | occurrences | 312 |
5 | bursts | 129 |
6 | diathesis | 91 |
7 | paroxysms | 44 |
8 | episodes/day | 23 |
9 | cystica | 14 |
10 | episodes/week | 14 |
11 | malunions | 12 |
12 | reinjuries | 11 |
13 | episodes/d | 9 |
14 | paracenteses | 9 |
15 | turnovers | 8 |
16 | confirmations | 7 |
17 | pilaris | 7 |
18 | viewings | 7 |
19 | emphysematosa | 4 |
20 | ossificans | 4 |
21 | comas | 3 |
22 | dyslipaemia | 3 |
23 | gestoses | 3 |
24 | nocturna | 3 |
25 | rehospitalisations | 3 |
26 | δk32-lamin | 3 |
27 | episodes/wk | 2 |
28 | fluroquinolones | 2 |
29 | hasao | 2 |
30 | hyperlipidemics | 2 |
31 | laboratory-infestations | 2 |
32 | lithiases | 2 |
33 | met-hours/week | 2 |
34 | setation | 2 |
35 | underpants | 2 |
36 | 0.010-0.118 | 1 |
37 | 1,3-diisopropylurea | 1 |
38 | 2-aminophen-oxazin-3-one | 1 |
39 | activities.most | 1 |
40 | calls/texts/visits | 1 |
41 | chandes | 1 |
42 | chloracetaldehyde | 1 |
43 | consulting-room | 1 |
44 | counter-realities | 1 |
45 | cyanogens | 1 |
46 | cyanophyte | 1 |
47 | disorders/anticoagulation | 1 |
48 | eavesdroppers | 1 |
49 | effects-one | 1 |
50 | grade/biopsy | 1 |
51 | monomethylmercury | 1 |
52 | organohalides | 1 |
53 | pauses/h | 1 |
54 | per-operatively | 1 |
55 | peroxynitrites | 1 |
56 | post-pvai | 1 |
57 | pretnancy | 1 |
58 | psycho-stimulating | 1 |
59 | questionnaire-quality | 1 |
60 | rate-cautis | 1 |
61 | rates.there | 1 |
62 | re-drying | 1 |
63 | requently | 1 |
64 | rotors/focal | 1 |
65 | rr=1,80 | 1 |
66 | serpentinization | 1 |
67 | taste.there | 1 |
68 | triggel | 1 |
69 | ureterica | 1 |
70 | vbfs | 1 |
71 | €19-157 | 1 |
72 | €77-260 | 1 |
73 | ≥5,000/µl | 1 |
74 | ▾roflumilast | 1 |
1 | 0.010-0.118 | 1 |
2 | 1,3-diisopropylurea | 1 |
3 | 2-aminophen-oxazin-3-one | 1 |
4 | activities.most | 1 |
5 | bursts | 129 |
6 | calls/texts/visits | 1 |
7 | chandes | 1 |
8 | chloracetaldehyde | 1 |
9 | comas | 3 |
10 | confirmations | 7 |
11 | consulting-room | 1 |
12 | counter-realities | 1 |
13 | cyanogens | 1 |
14 | cyanophyte | 1 |
15 | cystica | 14 |
16 | diathesis | 91 |
17 | disorders/anticoagulation | 1 |
18 | dyslipaemia | 3 |
19 | eavesdroppers | 1 |
20 | effects-one | 1 |
21 | emphysematosa | 4 |
22 | episodes | 8,863 |
23 | episodes/d | 9 |
24 | episodes/day | 23 |
25 | episodes/week | 14 |
26 | episodes/wk | 2 |
27 | fluroquinolones | 2 |
28 | gestoses | 3 |
29 | grade/biopsy | 1 |
30 | hasao | 2 |
31 | hyperlipidemics | 2 |
32 | incidents | 458 |
33 | laboratory-infestations | 2 |
34 | lithiases | 2 |
35 | malunions | 12 |
36 | met-hours/week | 2 |
37 | monomethylmercury | 1 |
38 | nocturna | 3 |
39 | occurrences | 312 |
40 | organohalides | 1 |
41 | ossificans | 4 |
42 | outbreaks | 498 |
43 | paracenteses | 9 |
44 | paroxysms | 44 |
45 | pauses/h | 1 |
46 | per-operatively | 1 |
47 | peroxynitrites | 1 |
48 | pilaris | 7 |
49 | post-pvai | 1 |
50 | pretnancy | 1 |
51 | psycho-stimulating | 1 |
52 | questionnaire-quality | 1 |
53 | rate-cautis | 1 |
54 | rates.there | 1 |
55 | re-drying | 1 |
56 | rehospitalisations | 3 |
57 | reinjuries | 11 |
58 | requently | 1 |
59 | rotors/focal | 1 |
60 | rr=1,80 | 1 |
61 | serpentinization | 1 |
62 | setation | 2 |
63 | taste.there | 1 |
64 | triggel | 1 |
65 | turnovers | 8 |
66 | underpants | 2 |
67 | ureterica | 1 |
68 | vbfs | 1 |
69 | viewings | 7 |
70 | δk32-lamin | 3 |
71 | €19-157 | 1 |
72 | €77-260 | 1 |
73 | ≥5,000/µl | 1 |
74 | ▾roflumilast | 1 |
1 | €77-260 | 1 |
2 | rr=1,80 | 1 |
3 | €19-157 | 1 |
4 | 0.010-0.118 | 1 |
5 | ureterica | 1 |
6 | cystica | 14 |
7 | 1,3-diisopropylurea | 1 |
8 | dyslipaemia | 3 |
9 | nocturna | 3 |
10 | emphysematosa | 4 |
11 | episodes/d | 9 |
12 | chloracetaldehyde | 1 |
13 | 2-aminophen-oxazin-3-one | 1 |
14 | effects-one | 1 |
15 | taste.there | 1 |
16 | rates.there | 1 |
17 | cyanophyte | 1 |
18 | psycho-stimulating | 1 |
19 | re-drying | 1 |
20 | pauses/h | 1 |
21 | post-pvai | 1 |
22 | episodes/week | 14 |
23 | met-hours/week | 2 |
24 | episodes/wk | 2 |
25 | rotors/focal | 1 |
26 | triggel | 1 |
27 | ≥5,000/µl | 1 |
28 | consulting-room | 1 |
29 | δk32-lamin | 3 |
30 | disorders/anticoagulation | 1 |
31 | setation | 2 |
32 | serpentinization | 1 |
33 | hasao | 2 |
34 | comas | 3 |
35 | hyperlipidemics | 2 |
36 | occurrences | 312 |
37 | organohalides | 1 |
38 | chandes | 1 |
39 | episodes | 8,863 |
40 | reinjuries | 11 |
41 | counter-realities | 1 |
42 | fluroquinolones | 2 |
43 | lithiases | 2 |
44 | paracenteses | 9 |
45 | gestoses | 3 |
46 | peroxynitrites | 1 |
47 | vbfs | 1 |
48 | viewings | 7 |
49 | pilaris | 7 |
50 | diathesis | 91 |
51 | rate-cautis | 1 |
52 | outbreaks | 498 |
53 | paroxysms | 44 |
54 | ossificans | 4 |
55 | cyanogens | 1 |
56 | malunions | 12 |
57 | confirmations | 7 |
58 | rehospitalisations | 3 |
59 | laboratory-infestations | 2 |
60 | eavesdroppers | 1 |
61 | turnovers | 8 |
62 | calls/texts/visits | 1 |
63 | underpants | 2 |
64 | incidents | 458 |
65 | bursts | 129 |
66 | ▾roflumilast | 1 |
67 | activities.most | 1 |
68 | episodes/day | 23 |
69 | pretnancy | 1 |
70 | per-operatively | 1 |
71 | requently | 1 |
72 | monomethylmercury | 1 |
73 | grade/biopsy | 1 |
74 | questionnaire-quality | 1 |